Clonal large granular lymphocyte (LGL) proliferations can arise from their normal T-or natural killer (NK)-cell counterparts. Both T-LGL and chronic NK-LGL leukemia/lymphocytosis are well-recognized disease entities in the World Health Organization (WHO) classification of hematopoietic malignancies.
LGL leukemia is a rare and heterogeneous disorder and most cases have an indolent clinical course. Its main clinical manifestations are related to chronic neutropenia and/or anemia. 1 Clonality assessment studies are essential to discriminate true LGL leukemia from other reactive proliferations. In T-LGL proliferations, clonality can easily be detected by PCR analysis of T-cell receptor (TCR) genes. In NK-LGL proliferations, clonality detection is difficult owing to the absence of specific clonality markers. Currently it is therefore unclear whether indolent NK-LGL leukemia, also known as chronic NK-LGL lymphocytosis or indolent NK-cell lymphoproliferative disorder, represents a reactive polyclonal process or a chronic phase of leukemia.
1 It was recently demonstrated that the NK cells in patients with molecularly (HUMARA X inactivation assay in female patients) proven monoclonal chronic NK-LGL lymphocytosis express an aberrant CD56 2 This immunophenotype is clearly different from the phenotype found in aggressive NK-cell leukemia and normal or reactive/activated NK-cell proliferations, which generally show high CD56 expression and a higher reactivity for CD11b. The aberrant immunophenotype of these NK-LGL cells could reflect underlying clonal genetic abnormalities.
In this study, we report on the clinical, hematological, immunophenotypical, serological and molecular features of a rare case diagnosed with T-LGL leukemia and a coexistent chronic NK-LGL leukemia.
A 73-year-old Caucasian man was admitted to the outpatient clinic in May 2005 with anemia and atypical blood lymphocytes. He had a 3-month history of fatigue, febrile episodes and painful ulcers on his tongue. He had suffered from severe mouth infections and a perianal abscess. Inspection of the oral cavity revealed an aphthous ulcer on the tongue with edema. Further physical examination was unremarkable, without evidence of lymphadenopathy, hepatosplenomegaly or skin lesions. Ultrasonography of the abdomen demonstrated a moderate splenomegaly.
Hematological examination revealed a white blood cell count of 8.3 Â 10 9 /l, with 92% lymphocytes, 5% neutrophils, 1% eosinophils and 2% monocytes. The hemoglobin (Hb) level was 9 g/dl and the platelet count 338 Â 10 9 /l. Lactate dehydrogenase levels (645 U/l) were elevated, whereas liver enzymes (aspartate aminotransferase/alanine amino transferase) were within normal range. Extensive serologic workout for hepatitis A, B and C virus, and HTLV-I and II showed no evidence for acute viral infection or reactivation, whereas examination of anti-cytomegalovirus (CMV), anti-Epstein-Barr virus (EBV) and anti-Parvo B19 virus antibodies demonstrated positive immunoglobulin G seroreactivity. Blood smears revealed 70% LGL cells with typical large nuclei and abundant cytoplasm containing fine azurophilic granules. Bone marrow (BM) aspiration showed hypercellular marrow with 56% LGLs. The BM biopsy was normocellular with lymphoid infiltration and slightly de-organized hematopoiesis. Immunohistochemical staining of the BM lymphoid infiltrate on tissue sections demonstrated diffuse and focal infiltration of CD2 þ lymphocytes. Only part of the infiltrate showed expression of CD3, CD5 and CD8. There was heterogeneous expression of CD57. The lymphoid cells were negative for CD4, CD30 and CD56. Staining for B-cell markers CD10, CD20 and CD79A only showed scattered B-lymphocytes and plasma cells.
Immunophenotyping was performed on peripheral blood (PB) and revealed large populations of T cells and NK cells, respectively 53 and 33% of total leukocytes ( Figure 1 ). The CD3 þ T-cell population was CD2, CD5 (dim), CD7, CD8, TCRab, CD57, HLA-DR, CD45RA, CD45RO, CD27, CD62L (dim), CD94 and CD197 (dim) positive. Cells were negative for CD16, CD56, CD11b, CD28 and perforin. TCR Vb flowcytometric analysis demonstrated the presence of 90% CD3
þ cells reactive with a TCR-Vb5.1 antibody (Figure 1 ). The CD3 À NKcell population was positive for CD2, CD7, CD16, CD57, HLA-DR (dim), CD28, CD62L, CD94, CD197 and perforin, but CD4, CD5, CD8, CD27, CD11b, CD56, CD45RA and CD45RO negative ( 
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À immunophenotype of the NK-LGL population (shown in black).
Letters to the Editor intolerance he received 10 mg weekly. During therapy he suffered from pneumococcal pneumonia with bacteremia from which the patient completely recovered. Finally, after 11 months of treatment with methotrexate, the blood count is improving with Hb level increasing to 12.5 g/dl and absolute neutrophil count of 2.0 Â 10 9 /l. It has been hypothesized that persistent, perhaps viral, antigenic stimulation underlies the pathogenesis of T-LGL and chronic NK-LGL leukemia. [3] [4] [5] As both diseases have developed in our patient, we speculate that the same antigen is involved in the pathogenesis of both T-and chronic NK-LGL leukemia. Whether the T-LGL or NK-LGL clones in our case were Parvo B19 virus or CMV-triggered remains uncertain. On top of that, a secondary molecular event is most probably required to establish the full malignant phenotype of the chronic antigen stimulated LGL population.
To gain further insight into the etiopathogenesis of the LGL proliferations in our patient, both T-LGL and NK-LGL subsets were purified. To this end, total PB MNCs from the patient were labelled with fluorochrome-conjugated monoclonal antibodies (CD45-PerCP (2D1), CD3-APC (SK7), CD16.56-PE (B73.1 and My31) BD Biosciences, San Jose, CA, USA), and VB5.1-FITC (LC4) (Immunotech, Marseille, France) for high speed cell sorting on a FACSDiVa cell sorter (BD Biosciences). Purity of the sorted populations was determined on the FACS Calibur (BD Biosciences) and shown to be 495% for both populations. Clonal TCRB and TCR gamma (TCRG) gene rearrangements could only be demonstrated in the sorted T-LGL population, and not in the NK-LGL subset. Southern blot analysis of both T-LGL and NK-LGL fractions showed the absence of clonal EBV genome. Array-based comparative genomic hybridization (CGH) analysis demonstrated only few subtle genetic alterations in the purified T-and NK-LGL fractions. Each population showed a different single clonal chromosomal abnormality, suggesting that the two cell proliferations did not have a common clonal origin. In the sorted T-LGL fraction a single copy loss of bacterial artificial chromosome (BAC) clone RP11-121A8 and a partial loss of the BAC clone RP11-273L18 (containing the TCRGV9 and TCRGV5 genes) located at 7p14.1 was observed. The clonal genetic alteration detected in the purified T-LGL subset most probably reflects physiological rearrangement of the TCRG locus. The purified NK-LGL fraction showed a gain of BAC clone RP11-440P5 (containing the BCL11A gene) located at 2p16.1. (Figure 2a and b) . The proto-oncogene BCL11A is involved in multiple lymphoid malignancies and BCL11A expression has been described in a case of NK-cell lymphoma. 7 Its possible role in the pathogenesis of chronic NK-LGL leukemia is not known. As the gain of 2p16.1 was not reflected by increased BCL11A messenger RNA expression (data not shown), we conclude that the gene is unlikely to be involved in malignant transformation in our case. Therefore, the pathologically relevant secondary genetic events are probably more subtle and remain to be identified. In line with this, in indolent LGL leukemia, cells most frequently have a normal karyotype and well-defined clonal chromosomal aberrations have been reported in few cases only. Array-based CGH analysis of purified leukemic T-LGL (a) and NK-LGL (b) populations. Blue dots represent clones within threshold (70.33 log2), whereas green (known polymorphic region) and red (altered region indicated by arrowhead) dots represent clones outside the threshold. Fabrication and validation of the array, hybridization methods and analytic procedures have been described elsewhere in detail, 6 whereas the clone content is available in the 'Cytoview' window of the Sanger Institute mapping database site, Ensembl (http://www.ensembl.org/).
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T-LGL leukemia in the presence of an NK-cell proliferation has been reported before, but the clonal nature of the NK-cell population could not be established. 8 The here presented case represents the first description of the coexistence of T-LGL and chronic NK-LGL populations with 'clonal' immunophenotype, which was confirmed by molecular studies. Remarkably, two different clonal chromosomal aberrations were present in the T-LGL and NK-LGL proliferations. Furthermore, this case illustrates the relatively indolent clinical course of T-LGL and chronic NK-LGL leukemia and confirms that genetic instability in LGL leukemias is less common and more subtle than in other mature T-/NK-cell malignancies.
Certain subtypes of childhood acute leukaemia are characterized by specific chromosomal translocations. Interestingly, some of these translocations have been shown to arise in utero as illustrated by their presence in neonatal blood spots from children, who later developed leukaemia.
1,2 Accordingly, information on risk factors for the prenatal emergence of such translocations, most likely representing an initial step in leukaemia development, are important to the understanding of childhood leukaemias.
Fusion gene transcripts resulting from chromosomal translocations can be detected and quantified by quantitative realtime polymerase chain reaction (qRT-PCR) using generic assays. Applied on cord blood samples, this technology may be relevant in the effort to characterize the epidemiology of pre-leukaemia, that is the prevalence and risk factors for pre-leukaemic cell clones in healthy neonates. 3 However, as RNA is very unstable, the sampling process in itself may result in RNA degradation and thus potentially false-negative results. This problem may be particularly pertinent to large-scale studies in which the time frame from sample collection to RNA processing extends beyond a few hours. Moreover, whereas the stability of house keeping and fusion gene transcripts has been assessed in peripheral blood and bone marrow, such information is not available for cord blood (CB) samples. 4, 5 In this study, we evaluated the significance of the time interval between acquisition of a CB sample and its processing, variable temperature during storing and the impact of RNA extraction protocols in degraded samples. The time-dependent degradation of RNAs in RNA unstabilized CB samples was evaluated by amplification of control genes and by mimicking a pre-leukaemic TEL-AML1-positive clone. Furthermore, we evaluated the use of a single-step method for purification of poly(A) þ RNA from cell lysate using paramagnetic oligo(dT) microbeads in comparison to total RNA in a TaqMan-based qRT-PCR set-up. 6 CB samples were collected into ethylenediaminetetraacetic acid Vacutainer tubes from 20 healthy newborns at the Clinic of Obstetrics, Copenhagen University Hospital, Denmark. In the first-sample set-up, the CB samples were divided into five identical tubes (1 ml whole CB per tube). The first tube was processed within an hour from sample collection (day 0), whereas the other four tubes were processed 24 (day 1), 48 (day 2), 72 (day 3) and 96 h (day 4) after sample collection. The
